SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 5.45% in the revenue at Rs. 6255.30 millions was reported in the December 2022 quarter as compared to Rs. 5932.10 millions during year-ago period.Net profit of the cmpany stood at Rs. 367.10 millions for the quarter ended December 2022 a decline of -34.27% from Rs. 558.50 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 699.50 millions from 923.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 6255.30 5932.10 5.45 18015.60 16097.00 11.92 22511.70 19148.90 17.56
Other Income 9.70 16.20 -40.12 13.00 41.50 -68.67 47.80 64.20 -25.55
PBIDT 699.50 923.00 -24.21 1951.90 2382.30 -18.07 3229.50 4077.00 -20.79
Interest 91.20 50.00 82.40 241.80 142.20 70.04 200.60 226.10 -11.28
PBDT 608.30 873.00 -30.32 1710.10 2240.10 -23.66 3028.90 3853.10 -21.39
Depreciation 118.70 119.50 -0.67 356.20 355.10 0.31 473.90 476.00 -0.44
PBT 489.60 753.50 -35.02 1353.90 1885.00 -28.18 2555.00 3377.10 -24.34
TAX 122.50 195.00 -37.18 357.50 465.00 -23.12 605.00 800.00 -24.38
Deferred Tax -12.50 -5.00 150.00 2.50 -15.00 -116.67 -50.00 -45.00 11.11
PAT 367.10 558.50 -34.27 996.40 1420.00 -29.83 1950.00 2577.10 -24.33
Equity 926.00 926.00 0.00 926.00 926.00 0.00 926.00 932.00 -0.64
PBIDTM(%) 11.18 15.56 -28.13 10.83 14.80 -26.79 14.35 21.29 -32.62

Aarti Drugs Share Price

354.75 -2.65 (-0.74%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×